loading...| Preferred Name |
Androstenediol |
|
| Synonyms |
5 Androstene 3,17 diol |
|
| Definitions |
An intermediate in TESTOSTERONE biosynthesis, found in the TESTIS or the ADRENAL GLANDS. Androstenediol, derived from DEHYDROEPIANDROSTERONE by the reduction of the 17-keto group (17-HYDROXYSTEROID DEHYDROGENASES), is converted to TESTOSTERONE by the oxidation of the 3-beta hydroxyl group to a 3-keto group (3-HYDROXYSTEROID DEHYDROGENASES). |
|
| ID |
http://purl.bioontology.org/ontology/MESH/D015114 |
|
| altLabel |
5 Androstene 3,17 diol delta 5 Androstene 3 beta,17 beta Diol 5-Androstene-3,17-diol Androst-5-ene-3 beta,17 beta-Diol Androst 5 ene 3 beta,17 beta Diol 5-Androstene-3beta-17beta-Diol Androst-5-ene-3,17-diol Androst-5-ene-3,17-diol, (3beta,17beta)- Androst 5 ene 3,17 diol delta 5-Androstene-3 beta,17 beta-Diol 5 Androstene 3beta 17beta Diol Bisexovister Delta 5-Androstenediol Hermaphrodiol Delta 5 Androstenediol |
|
| AQL |
AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR |
|
| cui |
C0524764 C1257717 |
|
| DC |
1 |
|
| definition |
An intermediate in TESTOSTERONE biosynthesis, found in the TESTIS or the ADRENAL GLANDS. Androstenediol, derived from DEHYDROEPIANDROSTERONE by the reduction of the 17-keto group (17-HYDROXYSTEROID DEHYDROGENASES), is converted to TESTOSTERONE by the oxidation of the 3-beta hydroxyl group to a 3-keto group (3-HYDROXYSTEROID DEHYDROGENASES). |
|
| DX |
19910101 |
|
| HN |
2004 (1976); use 5-ANDROSTENE-3,17-DIOL 1991-1997, use ANDROSTENEDIOLS 1976-1990 |
|
| Inverse of AQ |
http://purl.bioontology.org/ontology/MESH/Q000097 http://purl.bioontology.org/ontology/MESH/Q000627 http://purl.bioontology.org/ontology/MESH/Q000493 http://purl.bioontology.org/ontology/MESH/Q000494 http://purl.bioontology.org/ontology/MESH/Q000276 http://purl.bioontology.org/ontology/MESH/Q000138 http://purl.bioontology.org/ontology/MESH/Q000134 http://purl.bioontology.org/ontology/MESH/Q000266 http://purl.bioontology.org/ontology/MESH/Q000378 http://purl.bioontology.org/ontology/MESH/Q000008 http://purl.bioontology.org/ontology/MESH/Q000009 http://purl.bioontology.org/ontology/MESH/Q000031 http://purl.bioontology.org/ontology/MESH/Q000032 http://purl.bioontology.org/ontology/MESH/Q000037 http://purl.bioontology.org/ontology/MESH/Q000191 http://purl.bioontology.org/ontology/MESH/Q000302 http://purl.bioontology.org/ontology/MESH/Q000145 http://purl.bioontology.org/ontology/MESH/Q000592 http://purl.bioontology.org/ontology/MESH/Q000737 http://purl.bioontology.org/ontology/MESH/Q000819 http://purl.bioontology.org/ontology/MESH/Q000506 http://purl.bioontology.org/ontology/MESH/Q000633 http://purl.bioontology.org/ontology/MESH/Q000600 |
|
| Inverse of RB |
95PS51EMXY 0 |
|
| isa | ||
| LT |
TRD |
|
| Machine permutation |
2004; see ANDROST-5-ENE-3 BETA,17 BETA-DIOL 1998-2003, see 5-ANDROSTENE-3,17-DIOL 1991-1997, see ANDROSTENEDIOLS 1976-1990 |
|
| Mapped from |
http://purl.bioontology.org/ontology/MESH/C078543 |
|
| MDA |
19750718 |
|
| MMR |
20170524 |
|
| MN |
D06.472.334.851.968.750 D04.210.500.054.079.429.154.050 |
|
| notation |
D015114 |
|
| PA |
D045930 |
|
| prefLabel |
Androstenediol |
|
| RR |
521-17-5 (Androstenediol) |
|
| TERMUI |
T044150 T044152 T044149 T044153 T044151 T044148 T044147 T044154 T509139 |
|
| TH |
NLM (1976) FDA SRS (2014) ES UNK (19XX) NLM (1998) |
|
| tui |
T125 T109 T121 |
|
| subClassOf |